 |
 |
|
|
|  PubMed
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 April 2002 | Volume 136 Issue 8 | Pages 575-581
Background: The standard method of identifying persons at high risk for type 2 diabetes mellitus involves detection of impaired glucose tolerance, which requires a costly and inconvenient 2-hour oral glucose tolerance test. Because clinical trials have indicated that diabetes is preventable by using behavioral or pharmacologic interventions, less expensive methods of identifying high-risk persons are needed.
Objective: To determine whether multivariable models are superior to glucose tolerance tests for identifying persons at high risk for diabetes mellitus.
Design: Prospective cohort study.
Setting: San Antonio, Texas.
Participants: 1791 Mexican Americans and 1112 non-Hispanic whites without diabetes at baseline who were randomly selected from census tracts.
Measurements: Medical history; body mass index; blood pressure; fasting and 2-hour plasma glucose levels; fasting serum total, low-density lipoprotein, and high-density lipoprotein cholesterol levels; and triglyceride level.
Results: For prediction of 7.5-year incidence of type 2 diabetes, the area under the receiver-operating characteristic (ROC) curve for a multivariable model involving readily available clinical variables was significantly (P < 0.001) greater than the area under the ROC curve for the 2-hour glucose value alone (84.3% vs. 77.5%). Impaired glucose tolerance represents a single point on the latter curve. Adding the 2-hour glucose measurement to the multivariable model increased the area under its ROC curve, but only from 84.3% to 85.7%.
Conclusion: Persons at high risk for diabetes mellitus are better identified by using a simple prediction model than by relying exclusively on the results of a 2-hour oral glucose tolerance test. Although adding the 2-hour glucose variable to the model enhanced prediction, the resulting slight improvement entails greater cost and inconvenience.
Editors' Notes
Context
Contribution
Cautions
–The Editors
Author and Article Information
From University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Acknowledgment: The authors thank Dr. Agustin Escalante for providing helpful advice on the evaluation of ROC curves.
Grant Support: By the National Heart, Lung, and Blood Institute (grants RO1 HL24799 and RO1 HL36820).
Requests for Single Reprints: Michael P. Stern, MD, Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900; e-mail, stern{at}uthscsa.edu.
Current Author Addresses: Drs. Stern and Haffner and Mr. Williams: Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900.
Author Contributions: Conception and design: M.P. Stern, S.M. Haffner.
Analysis and interpretation of the data: M.P. Stern, K. Williams, S.M. Haffner.
Drafting of the article: M.P. Stern, K. Williams.
Critical revision of the article for important intellectual content: M.P. Stern, K. Williams, S.M. Haffner.
Final approval of the article: M.P. Stern, K. Williams, S.M. Haffner.
Statistical expertise: K. Williams.
Obtaining of funding: M.P. Stern.
Administrative, technical, or logistic support: M.P. Stern.
Collection and assembly of data: M.P. Stern, S.M. Haffner. ARTICLE
Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test?
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J. B. Meigs Multiple Biomarker Prediction of Type 2 Diabetes Diabetes Care, July 1, 2009; 32(7): 1346 - 1348. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Kolberg, T. Jorgensen, R. W. Gerwien, S. Hamren, M. P. McKenna, E. Moler, M. W. Rowe, M. S. Urdea, X. M. Xu, T. Hansen, et al. Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort Diabetes Care, July 1, 2009; 32(7): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kahn, Y. J. Cheng, T. J. Thompson, G. Imperatore, and E. W. Gregg Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years Ann Intern Med, June 2, 2009; 150(11): 741 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Herman Predicting Risk for Diabetes: Choosing (or Building) the Right Model Ann Intern Med, June 2, 2009; 150(11): 812 - 814. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Goldberg, M. Temprosa, S. Haffner, T. J. Orchard, R. E. Ratner, S. E. Fowler, K. Mather, S. Marcovina, C. Saudek, M. J. Matulik, et al. Effect of Progression From Impaired Glucose Tolerance to Diabetes on Cardiovascular Risk Factors and Its Amelioration by Lifestyle and Metformin Intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group Diabetes Care, April 1, 2009; 32(4): 726 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Ley, S. B. Harris, M. Mamakeesick, T. Noon, E. Fiddler, J. Gittelsohn, T. M.S. Wolever, P. W. Connelly, R. A. Hegele, B. Zinman, et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community Can. Med. Assoc. J., March 17, 2009; 180(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hippisley-Cox, C. Coupland, J. Robson, A. Sheikh, and P. Brindle Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore BMJ, March 17, 2009; 338(mar17_2): b880 - b880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. H. Schwarz, J. Li, M. Reimann, A. E. Schutte, A. Bergmann, M. Hanefeld, S. R. Bornstein, J. Schulze, J. Tuomilehto, and J. Lindstrom The Finnish Diabetes Risk Score Is Associated with Insulin Resistance and Progression towards Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 920 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, V. Lyssenko, T. Tuomi, R. A. DeFronzo, and L. Groop Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study Diabetes Care, February 1, 2009; 32(2): 281 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Meigs, P. Shrader, L. M. Sullivan, J. B. McAteer, C. S. Fox, J. Dupuis, A. K. Manning, J. C. Florez, P. W.F. Wilson, R. B. D'Agostino Sr., et al. Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes N. Engl. J. Med., November 20, 2008; 359(21): 2208 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lyssenko, A. Jonsson, P. Almgren, N. Pulizzi, B. Isomaa, T. Tuomi, G. Berglund, D. Altshuler, P. Nilsson, and L. Groop Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes N. Engl. J. Med., November 20, 2008; 359(21): 2220 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden American College of Endocrinology Pre-Diabetes Consensus Conference: Part One Diabetes Care, October 1, 2008; 31(10): 2062 - 2069. [Full Text] [PDF]
|
|
|
|
|
|
B. Balkau, C. Lange, L. Fezeu, J. Tichet, B. de Lauzon-Guillain, S. Czernichow, F. Fumeron, P. Froguel, M. Vaxillaire, S. Cauchi, et al. Predicting Diabetes: Clinical, Biological, and Genetic Approaches: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care, October 1, 2008; 31(10): 2056 - 2061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Ford, C. Li, and N. Sattar Metabolic Syndrome and Incident Diabetes: Current state of the evidence Diabetes Care, September 1, 2008; 31(9): 1898 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, and R. A. DeFronzo One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes Diabetes Care, August 1, 2008; 31(8): 1650 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stern, K. Williams, D. Eddy, and R. Kahn Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models Diabetes Care, August 1, 2008; 31(8): 1670 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, June 3, 2008; 148(11): 855 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahman, R. K Simmons, A.-H. Harding, N. J Wareham, and S. J Griffin A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study Fam. Pract., June 1, 2008; 25(3): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Heikes, D. M. Eddy, B. Arondekar, and L. Schlessinger Diabetes Risk Calculator: A simple tool for detecting undiagnosed diabetes and pre-diabetes Diabetes Care, May 1, 2008; 31(5): 1040 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Seidel, R. O. Powell, J. C. Zgibor, L. M. Siminerio, and G. A. Piatt Translating the Diabetes Prevention Program Into an Urban Medically Underserved Community: A nonrandomized prospective intervention study Diabetes Care, April 1, 2008; 31(4): 684 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Rosal, E. M. Benjamin, P. S. Pekow, S. C. Lemon, and D. von Goeler Opportunities and Challenges for Diabetes Prevention at Two Community Health Centers Diabetes Care, February 1, 2008; 31(2): 247 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Schooling, C. Jiang, T. H. Lam, G. N. Thomas, M. Heys, Bmbs, X. Lao, W. Zhang, P. Adab, K. K. Cheng, et al. Height, Its Components, and Cardiovascular Risk Among Older Chinese: A Cross-Sectional Analysis of the Guangzhou Biobank Cohort Study Am J Public Health, October 1, 2007; 97(10): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Valdez, K. J. Greenlund, M. J. Khoury, and P. W. Yoon Is Family History a Useful Tool for Detecting Children at Risk for Diabetes and Cardiovascular Diseases? A Public Health Perspective Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S78 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, K. Williams, R. A. DeFronzo, and M. Stern What Is the Best Predictor of Future Type 2 Diabetes? Diabetes Care, June 1, 2007; 30(6): 1544 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. F. Wilson, J. B. Meigs, L. Sullivan, C. S. Fox, D. M. Nathan, and R. B. D'Agostino Sr Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study Arch Intern Med, May 28, 2007; 167(10): 1068 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. De Hert, L. Hanssens, R. van Winkel, M. Wampers, D. Van Eyck, A. Scheen, and J. Peuskens A Case Series: Evaluation of the Metabolic Safety of Aripiprazole Schizophr Bull, May 1, 2007; 33(3): 823 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Schulze, K. Hoffmann, H. Boeing, J. Linseisen, S. Rohrmann, M. Mohlig, A. F.H. Pfeiffer, J. Spranger, C. Thamer, H.-U. Haring, et al. An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes Diabetes Care, March 1, 2007; 30(3): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care Diabetes Care, March 1, 2007; 30(3): 753 - 759. [Full Text] [PDF]
|
|
|
|
|
|
M. B. Davidson Clinical Implications of the DREAM Study Diabetes Care, February 1, 2007; 30(2): 418 - 420. [Full Text] [PDF]
|
|
|
|
|
|
O. Cohen, R. Basu, G. Bock, C. Dalla Man, M. Campioni, A. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength Diabetes Care, December 1, 2006; 29(12): 2708 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Aekplakorn, P. Bunnag, M. Woodward, P. Sritara, S. Cheepudomwit, S. Yamwong, T. Yipintsoi, and R. Rajatanavin A Risk Score for Predicting Incident Diabetes in the Thai Population Diabetes Care, August 1, 2006; 29(8): 1872 - 1877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Abdul-Ghani, K. Williams, R. DeFronzo, and M. Stern Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma Glucose Diabetes Care, July 1, 2006; 29(7): 1613 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Brunner, M. J. Shipley, D. R. Witte, J. H. Fuller, and M. G. Marmot Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study Diabetes Care, January 1, 2006; 29(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.G. Hanley, A. J. Karter, K. Williams, A. Festa, R. B. D'Agostino Jr, L. E. Wagenknecht, and S. M. Haffner Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Circulation, December 13, 2005; 112(24): 3713 - 3721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. LaMonte, S. N. Blair, and T. S. Church Physical activity and diabetes prevention J Appl Physiol, September 1, 2005; 99(3): 1205 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Schmidt, B. B. Duncan, H. Bang, J. S. Pankow, C. M. Ballantyne, S. H. Golden, A. R. Folsom, L. E. Chambless, and for the Atherosclerosis Risk in Communities Invest Identifying Individuals at High Risk for Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, August 1, 2005; 28(8): 2013 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Levantesi, A. Macchia, R. Marfisi, M. G. Franzosi, A. P. Maggioni, G. L. Nicolosi, C. Schweiger, L. Tavazzi, G. Tognoni, F. Valagussa, et al. Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sedor and J. R. Schelling Association of Metabolic Syndrome in Nondiabetic Patients with Increased Risk for Chronic Kidney Disease: The Fat Lady Sings J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Orchard, M. Temprosa, R. Goldberg, S. Haffner, R. Ratner, S. Marcovina, S. Fowler, and for the Diabetes Prevention Program Research Group The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial Ann Intern Med, April 19, 2005; 142(8): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tuomilehto Primary Prevention of Type 2 Diabetes: Lifestyle Intervention Works and Saves Money, but What Should Be Done with Smokers? Ann Intern Med, March 1, 2005; 142(5): 381 - 383. [Full Text] [PDF]
|
|
|
|
|
|
W. Rathmann, S. Martin, B. Haastert, A. Icks, R. Holle, H. Lowel, G. Giani, and for the KORA Study Group Performance of Screening Questionnaires and Risk Scores for Undiagnosed Diabetes: The KORA Survey 2000 Arch Intern Med, February 28, 2005; 165(4): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kanaya, C. L. W. Fyr, N. de Rekeneire, R. I. Shorr, A. V. Schwartz, B. H. Goodpaster, A. B. Newman, T. Harris, and E. Barrett-Connor Predicting the Development of Diabetes in Older Adults: The derivation and validation of a prediction rule Diabetes Care, February 1, 2005; 28(2): 404 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Prevention Program Research Group Strategies to Identify Adults at High Risk for Type 2 Diabetes: The Diabetes Prevention Program Diabetes Care, January 1, 2005; 28(1): 138 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, et al. Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes Diabetes, January 1, 2005; 54(1): 166 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, K. Williams, C. Gonzalez-Villalpando, K. J. Hunt, and S. M. Haffner Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care, November 1, 2004; 27(11): 2676 - 2681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs Metabolic Syndrome: In search of a clinical role Diabetes Care, November 1, 2004; 27(11): 2761 - 2763. [Full Text] [PDF]
|
|
|
|
|
|
A. W. Lyon, E. T. Larsen, and A. L. Edwards The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services Can. Med. Assoc. J., October 26, 2004; 171(9): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
|
|
E. Chiquette, G. Ramirez, and R. DeFronzo A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors Arch Intern Med, October 25, 2004; 164(19): 2097 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nikander, A. Tiitinen, K. Laitinen, M. Tikkanen, and O. Ylikorkala Effects of Isolated Isoflavonoids on Lipids, Lipoproteins, Insulin Sensitivity, and Ghrelin in Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3567 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Tai, S. Y. Goh, J. J.M. Lee, M.-S. Wong, D. Heng, K. Hughes, S. K. Chew, J. Cutter, W. Chew, K. Gu, et al. Lowering the Criterion for Impaired Fasting Glucose: Impact on disease prevalence and associated risk of diabetes and ischemic heart disease Diabetes Care, July 1, 2004; 27(7): 1728 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, A. Festa, R. B. D'Agostino, L. E. Wagenknecht, P. J. Savage, R. P. Tracy, M. F. Saad, and S. M. Haffner Metabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes: Factor Analysis Using Directly Measured Insulin Sensitivity Diabetes, July 1, 2004; 53(7): 1773 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, K. Williams, L. M. Sullivan, K. J. Hunt, S. M. Haffner, M. P. Stern, C. Gonzalez Villalpando, J. S. Perhanidis, D. M. Nathan, R. B. D'Agostino Jr, et al. Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance Diabetes Care, June 1, 2004; 27(6): 1417 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]
|
|
|
|
|
|
W.E. Feeman Jr, N. Sattar, D. S. J. O'Reilly, C. J. Packard, J. Shepherd, A. Gaw, P. W. Macfarlane, S. M. Cobbe, O. Scherbakova, I. Ford, et al. Metabolic Syndrome and Diabetes Mellitus Circulation, January 27, 2004; 109 (3): e23 - e23. [Full Text] [PDF]
|
|
|
|
|
|
M. J. McNeely and E. J. Boyko Type 2 Diabetes Prevalence in Asian Americans: Results of a national health survey Diabetes Care, January 1, 2004; 27(1): 66 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]
|
|
|
|
|
|
C. Lorenzo, M. Okoloise, K. Williams, M. P. Stern, and S. M. Haffner The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study Diabetes Care, November 1, 2003; 26(11): 3153 - 3159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Prevention of Obesity and Diabetes Diabetes Care, November 1, 2003; 26(11): 3172 - 3178. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, P. W.F. Wilson, D. M. Nathan, R. B. D'Agostino Sr., K. Williams, and S. M. Haffner Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies Diabetes, August 1, 2003; 52(8): 2160 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging Diabetes, June 1, 2003; 52(6): 1475 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Schmidt, B. B. Duncan, A. Vigo, J. Pankow, C. M. Ballantyne, D. Couper, F. Brancati, and A. R. Folsom Detection of Undiagnosed Diabetes and Other Hyperglycemia States: The Atherosclerosis Risk in Communities Study Diabetes Care, May 1, 2003; 26(5): 1338 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lindstrom and J. Tuomilehto The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk Diabetes Care, March 1, 2003; 26(3): 725 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. McNeely, E. J. Boyko, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese Americans Diabetes Care, March 1, 2003; 26(3): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, K. Williams, and S. M. Haffner Do We Need the Oral Glucose Tolerance Test to Identify Future Cases of Type 2 Diabetes? Diabetes Care, March 1, 2003; 26(3): 940 - 941. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Cardiovascular Disease and Diabetes Diabetes Care, January 1, 2003; 26(1): 230 - 237. [Full Text] [PDF]
|
|
|
|
|
|
G. Bombassei Optimal Prediction of Diabetes Ann Intern Med, November 19, 2002; 137(10): 856 - 856. [Full Text] [PDF]
|
|
|
|
|
|
T. S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M. E.J. Lean, and S. M. Haffner Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study Diabetes Care, November 1, 2002; 25(11): 2016 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Engelgau, K.M. Venkat Narayan, and F. Vinicor Identifying the Target Population for Primary Prevention: The Trade-Offs Diabetes Care, November 1, 2002; 25(11): 2098 - 2099. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Stern, P. Fatehi, K. Williams, and S. M. Haffner Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test? Diabetes Care, October 1, 2002; 25(10): 1851 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tuomilehto Point: A Glucose Tolerance Test Is Important for Clinical Practice Diabetes Care, October 1, 2002; 25(10): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
|
|
K. Afsari and J. P. Posin Central Pontine Myelinolysis Ann Intern Med, September 17, 2002; 137(6): 553 - 553. [Full Text] [PDF]
|
|
|
|
|
|
K M V. Narayan, G. Imperatore, S. M Benjamin, and M. M Engelgau Targeting people with pre-diabetes BMJ, August 24, 2002; 325(7361): 403 - 404. [Full Text] [PDF]
|
|
